Sign In
Get Clay Free →

Suggestions

    Brad Lanoue

    Executive Director - Global Access Disease/Product Lead at Novartis Oncology

    Brad Lanoue is currently the Vice President of Global and US Value and Market Access at Arvinas, a position he has held since March 2023.12 Prior to this role, he worked at Novartis Oncology for over 20 years in various positions, including:

    1. Worldwide Access Disease Leader - Breast and Women's Cancers (Executive Director) from October 2019 to March 2023.1
    2. Executive Director - Global Value and Access Launch Lead (Kisqali) from July 2016 to October 2019.1
    3. Senior Director, Global Access Franchise Lead - New Products and Rare Diseases from February 2015 to July 2016.1

    Brad has extensive experience in the pharmaceutical industry, particularly in marketing and market access with a focus on oncology.2 He played a significant role in the launch of KISQALI®, a treatment for advanced breast cancer, leading the development and execution of the Global Value and Access launch strategy.2

    Brad Lanoue holds an M.Sc. specializing in Developmental Genetics and a B.Sc. in Biology, both from McMaster University in Hamilton, Ontario, Canada.12

    Highlights

    Nov 3 · theorg.com
    Brad Lanoue - VP, Global & U.S. Value & Market Access Strategy at ...
    Brad Lanoue - VP, Global & U.S. Value & Market Access Strategy at ...
    Jul 1 · arvinas.com
    Leadership Bios Archive - Page 3 of 6 - Arvinas
    Leadership Bios Archive - Page 3 of 6 - Arvinas

    Related Questions

    What are Brad Lanoue's main responsibilities at Arvinas?
    How did Brad Lanoue transition from Novartis Oncology to Arvinas?
    What are some of the key projects Brad Lanoue has led at Novartis Oncology?
    What is Brad Lanoue's educational background?
    How has Brad Lanoue's career evolved over the past two decades?
    Brad Lanoue
    Brad Lanoue, photo 1
    Brad Lanoue, photo 2
    Add to my network

    Location

    Morristown, New Jersey, United States